SUBHASH KUMAR WANGNOO

519 total citations
38 papers, 233 citations indexed

About

SUBHASH KUMAR WANGNOO is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, SUBHASH KUMAR WANGNOO has authored 38 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 6 papers in Genetics. Recurrent topics in SUBHASH KUMAR WANGNOO's work include Diabetes Management and Research (20 papers), Diabetes Treatment and Management (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). SUBHASH KUMAR WANGNOO is often cited by papers focused on Diabetes Management and Research (20 papers), Diabetes Treatment and Management (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). SUBHASH KUMAR WANGNOO collaborates with scholars based in India, United States and Netherlands. SUBHASH KUMAR WANGNOO's co-authors include Mohammad A. Siddiqui, Abida Malik, Mohammad Zubair, Jamal Ahmad, Nitin Gupta, Ignacio Conget, Peter M. Nilsson, Alfred Penfornis, Giovanni Bader and Banshi Saboo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

SUBHASH KUMAR WANGNOO

30 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SUBHASH KUMAR WANGNOO India 8 132 36 34 28 23 38 233
Mircea-Cătălin Forțofoiu Romania 10 59 0.4× 52 1.4× 33 1.0× 17 0.6× 49 2.1× 43 256
Sheraz Fazid Pakistan 6 82 0.6× 17 0.5× 30 0.9× 12 0.4× 49 2.1× 17 220
Uditha Bulugahapitiya Sri Lanka 8 173 1.3× 95 2.6× 35 1.0× 47 1.7× 63 2.7× 26 371
Hua Qiang China 7 91 0.7× 39 1.1× 67 2.0× 7 0.3× 37 1.6× 16 277
José Miguel González-Clemente Spain 10 123 0.9× 52 1.4× 57 1.7× 11 0.4× 78 3.4× 18 339
Dragana Lovre United States 10 110 0.8× 28 0.8× 58 1.7× 38 1.4× 27 1.2× 17 265
Vatcharapan Umpaichitra United States 11 129 1.0× 77 2.1× 34 1.0× 18 0.6× 43 1.9× 30 289
Asma Maqsood Pakistan 6 208 1.6× 36 1.0× 22 0.6× 3 0.1× 82 3.6× 11 333
Roshan Kumar Mahat India 10 58 0.4× 24 0.7× 45 1.3× 92 3.3× 60 2.6× 23 276
Matthias Hepprich Switzerland 9 82 0.6× 72 2.0× 53 1.6× 114 4.1× 48 2.1× 25 326

Countries citing papers authored by SUBHASH KUMAR WANGNOO

Since Specialization
Citations

This map shows the geographic impact of SUBHASH KUMAR WANGNOO's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SUBHASH KUMAR WANGNOO with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SUBHASH KUMAR WANGNOO more than expected).

Fields of papers citing papers by SUBHASH KUMAR WANGNOO

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SUBHASH KUMAR WANGNOO. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SUBHASH KUMAR WANGNOO. The network helps show where SUBHASH KUMAR WANGNOO may publish in the future.

Co-authorship network of co-authors of SUBHASH KUMAR WANGNOO

This figure shows the co-authorship network connecting the top 25 collaborators of SUBHASH KUMAR WANGNOO. A scholar is included among the top collaborators of SUBHASH KUMAR WANGNOO based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SUBHASH KUMAR WANGNOO. SUBHASH KUMAR WANGNOO is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seshadri, Krishna, Viswanathan Mohan, SUBHASH KUMAR WANGNOO, et al.. (2025). Imeglimin in Type 2 Diabetes Mellitus: Expert Opinions and Consensus in Indian Context. Journal of the Association of Physicians of India. 73(6). e15–e22.
2.
WANGNOO, SUBHASH KUMAR, Sanjay Kumar Bhadada, Gita Naidu, et al.. (2025). Safety and efficacy of fixed-dose combination of dapagliflozin and saxagliptin in patients with type 2 diabetes mellitus – a phase 4 study in India. Frontiers in Endocrinology. 16. 1528801–1528801.
3.
WANGNOO, SUBHASH KUMAR, et al.. (2025). In-Hospital Management of Hyperglycemia: The Role of Insulin Degludec. Diabetes Therapy. 16(4). 547–568.
4.
Das, Ashok Kumar, Sanjay Kalra, Shashank Joshi, et al.. (2023). The LongitudinAl Nationwide stuDy on Management And Real‐world outComes of diabetes in India over 3 years (LANDMARC trial). Endocrinology Diabetes & Metabolism. 6(5). e422–e422. 1 indexed citations
5.
Das, Ashok Kumar, Sanjay Kalra, Shashank Joshi, et al.. (2023). Two‐year trends from the LANDMARC study: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcome in patients with type 2 diabetes mellitus. Endocrinology Diabetes & Metabolism. 6(2). e404–e404. 1 indexed citations
6.
Kalra, Sanjay, AG Unnikrishnan, K.M. PRASANNA KUMAR, et al.. (2022). Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India. Diabetes Therapy. 14(1). 29–45. 3 indexed citations
7.
Mohan, Viswanathan, et al.. (2022). Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review. World Journal of Diabetes. 13(12). 1168–1183. 1 indexed citations
8.
Unnikrishnan, AG, Rakesh Sahay, Parag Shah, et al.. (2022). Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. PLoS ONE. 17(3). e0263619–e0263619. 16 indexed citations
9.
WANGNOO, SUBHASH KUMAR, et al.. (2021). Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India. SHILAP Revista de lepidopterología. 4. 100102–100102. 1 indexed citations
10.
WANGNOO, SUBHASH KUMAR, et al.. (2020). Worldwide spread of COVID-19 Pandemic and risk factors among Co-morbid conditions especially Diabetes Mellitus in India. Research Journal of Pharmacy and Technology. 13(5). 2530–2530. 28 indexed citations
11.
WANGNOO, SUBHASH KUMAR, et al.. (2018). Impact of glycemic levels in Type 2 diabetes on periodontitis. Indian Journal of Endocrinology and Metabolism. 22(5). 672–672. 21 indexed citations
12.
Siddiqui, Mohammad A., et al.. (2015). Prevalence of glucose intolerance at 6 weeks postpartum in Indian women with gestational diabetes mellitus. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 9(3). 143–146. 19 indexed citations
13.
WANGNOO, SUBHASH KUMAR. (2015). Diabetic foot: Clinical presentation and management in 2015. Journal of Indian College of Cardiology. 6. 58–60. 2 indexed citations
14.
Kesavadev, Jothydev, S.M. Sadikot, SUBHASH KUMAR WANGNOO, et al.. (2014). Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 8(3). 187–195. 8 indexed citations
15.
Ahmad, Ayesha, et al.. (2013). Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 8(1). 45–47. 3 indexed citations
16.
Mathieu, Chantal, Anthony Barnett, Helmut Brath, et al.. (2013). Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (EDGE). International Journal of Clinical Practice. 67(10). 947–956. 42 indexed citations
17.
Ahmad, Ayesha, et al.. (2012). Is 46XX karyotype always a female?. BMJ Case Reports. 2012. bcr2012006223–bcr2012006223. 4 indexed citations
18.
Ahmad, Jamal, Mohammad Zubair, Abida Malik, Mohammad A. Siddiqui, & SUBHASH KUMAR WANGNOO. (2012). Cathepsin-D, Adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: A multicentric study. The Foot. 22(3). 194–199. 30 indexed citations
19.
Gupta, Mukul Kumar, et al.. (2011). Safety profile of Vildagliptin in clinical practice: 2-year data from 2 Tertiary hospitals. 25. 1 indexed citations
20.
WANGNOO, SUBHASH KUMAR, et al.. (2009). Adult Growth Hormone Deficiency. SHILAP Revista de lepidopterología. 6(4). 340–346.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mircea-Cătălin Forțofoiu Breakdown of academic impact, for papers by Sheraz Fazid Breakdown of academic impact, for papers by Uditha Bulugahapitiya Breakdown of academic impact, for papers by Hua Qiang Breakdown of academic impact, for papers by José Miguel González-Clemente Breakdown of academic impact, for papers by Dragana Lovre Breakdown of academic impact, for papers by Vatcharapan Umpaichitra Breakdown of academic impact, for papers by Asma Maqsood Breakdown of academic impact, for papers by Roshan Kumar Mahat Breakdown of academic impact, for papers by Matthias Hepprich
Rankless by CCL
2026